Working toward more effective tuberculosis vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with “kill switches” that can be triggered to stop the bacteria after they activate an immune response.
On January 10, 2025, The USDA honored Cornell University’s Breeding Insight through the USDA Honor Awards program, celebrating their contributions to providing all Americans with safe, nutritious food.
Weill Cornell Medicine physician-scientists Dr. Niroshana Anandasabapathy and Dr. Rohit Chandwani have been elected members of the American Society for Clinical Investigation for 2025.
A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.
The new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine.
Health information technology systems promised increased efficiency and reduced costs, but new ILR School-led research suggests these benefits have been elusive.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.
Almost 50 million Americans – disproportionately in rural areas – must drive 25 miles or more to access a gastroenterologist for diagnosis and treatment of issues involving the digestive system, according to a study from Weill Cornell Medicine researchers.
Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.